about
Migraine in the era of precision medicineTreatment of Chronic Migraine with Focus on Botulinum NeurotoxinsBistable dynamics underlying excitability of ion homeostasis in neuron modelsMinority Representation in Migraine Treatment Trials.A genetic risk score is differentially associated with migraine with and without aura.Examining a possible association between human papilloma virus (HPV) vaccination and migraine: results of a cohort study in the NetherlandsMigraine and risk of stroke in older adults: Northern Manhattan Study.Genetic forms of epilepsies and other paroxysmal disordersEarly-onset familial hemiplegic migraine due to a novel SCN1A mutation.Pediatric headache: where have we been and where do we need to be.Our evolving understanding of migraine with aura.Association of age at onset of migraine with family history of migraine in children attending a pediatric headache clinic: a retrospective cohort study.Properties, regulation, pharmacology, and functions of the K₂p channel, TRESK.Migraine and epilepsy: review of the literature.Genetic epidemiology of migraine and depression.A retrospective analysis of triptan and dhe use for basilar and hemiplegic migraine.Genetics of Migraine: Insights into the Molecular Basis of Migraine Disorders.Common polygenic variation contributes to risk of migraine in the Norfolk Island population.Headache and peak oxygen uptake: The HUNT3 study.Evidence for linkage of migraine in Rolandic epilepsy to known 1q23 FHM2 and novel 17q22 genetic loci.Epidemiology of migraine among students in Mali.Brain activity patterns in high-throughput electrophysiology screen predict both drug efficacies and side effects.
P2860
Q26748947-E4BB231D-239D-43AB-A530-E65DBE79629DQ26799906-EF3C1694-2A6F-4951-B960-64A290FB8186Q28538303-7D2E8E7B-7643-45AD-85A1-96CF0329A1B4Q30238764-4BE96711-BCF6-4ACC-8EFF-202081A25547Q33885473-4A3F86EC-D22E-440D-AFD9-59F0159137D7Q35546272-D7B3713F-969A-4AF9-9617-E7F696B8D40EQ36005662-3D41D387-D0A9-4659-8D40-F81F15C05BABQ36805699-EF322451-DC52-414D-81D5-7E7F3D03C0D2Q37408962-45FB1FF1-4285-4970-8D1E-A248AD5B2DCCQ38205900-15564D9F-60E2-4A49-B77D-227C1621C774Q38250479-27A6609C-BC9C-4A13-8B6B-772895E423CBQ38259063-C2E49E4B-4E66-4280-9627-5CC3008BA832Q38264680-22B6303A-E2BD-4518-A36F-87D6CC008F00Q38371291-46A2728C-217D-465B-AB03-5E76B2BE971DQ38769614-DE7F1749-8FE8-40D0-A8AC-8A98DFDB2830Q38803468-5293DD99-948A-4512-92D9-4625556973A4Q39167599-2D8F87CF-6ABC-4520-96F8-60BDC590AD09Q41536342-811691AA-833E-4195-8954-039DE9F27812Q41552067-AE6436A7-DCB4-4BD7-ADBD-F3D879E7D055Q45217603-6F5B9E1A-6FF6-4DBB-BA47-1D3195E0D1E0Q47109178-4F41E5F9-5368-4BDD-AEB8-1C4A04A1716BQ47863623-6F419918-6174-499F-BF27-4DAC8146DBF6
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Migraine genetics: Part II.
@en
type
label
Migraine genetics: Part II.
@en
prefLabel
Migraine genetics: Part II.
@en
P2860
P356
P1433
P1476
Migraine genetics: Part II.
@en
P2860
P304
P356
10.1111/HEAD.12169
P577
2013-08-06T00:00:00Z